Effects of the metals on dihydropteridine reductase activity

被引:10
作者
Altindag, ZZ [1 ]
Baydar, T [1 ]
Engin, AB [1 ]
Sahin, G [1 ]
机构
[1] Hacettepe Univ, Fac Pharm, Dept Toxicol, TR-06100 Ankara, Turkey
关键词
dihydropteridine reductase; metal; biomarker; environmental pollutants;
D O I
10.1016/S0887-2333(03)00136-X
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Metals are the oldest toxins known to human. Particularly, occupational and environmental exposure to aluminium, lead, mercury, cadmium, and manganese cause serious health problems by interaction with biological systems. Cellular targets of these metals are mostly specific biochemical processes (enzymes) and/or membranes of cells and organelles. To prevent and/or reduce the untoward or irreversible toxic effects of the metals by using biomarkers are as important as to know and to understand of their toxicity mechanisms. Dihydropteridine reductase (DHPR), which possessed essential thiol groups at the activite site, plays a crucial role in the maintenance of tetrahydrobiopterin (BH4). BH4 iS the cofactor in the synthesis and regulation of neurotransmitters. A limited number of the evidences have shown that DHPR may be a target for the metals. Therefore, the present study was designed to assess possible in vitro effects of the commonly exposed metals on the enzyme activity. It was found that aluminium, cadmium, mercury, di-phenyl mercury, lead, diethyl lead, in chloride forms, and manganese, in sulphate form, led to statistically significant decreases in DHPR activity, in a concentration-dependent manner, in vitro. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:533 / 537
页数:5
相关论文
共 17 条
[1]  
ABELSON HT, 1979, BLOOD, V53, P116
[2]  
Altindag ZZ, 1996, PHARM SCI, V2, P335
[3]   DISTURBANCE OF CEREBRAL FUNCTION BY ALUMINUM IN HEMODIALYSIS-PATIENTS WITHOUT OVERT ALUMINUM TOXICITY [J].
ALTMANN, P ;
DHANESHA, U ;
HAMON, C ;
CUNNINGHAM, J ;
BLAIR, J ;
MARSH, F .
LANCET, 1989, 2 (8653) :7-12
[4]   SERUM ALUMINUM LEVELS AND ERYTHROCYTE DIHYDROPTERIDINE REDUCTASE-ACTIVITY IN PATIENTS ON HEMODIALYSIS [J].
ALTMANN, P ;
ALSALIHI, F ;
BUTTER, K ;
CUTLER, P ;
BLAIR, J ;
LEEMING, R ;
CUNNINGHAM, J ;
MARSH, F .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (02) :80-84
[5]  
ARAI N, 1982, PEDIATRICS, V70, P426
[6]   INACTIVATION OF DIHYDROPTERIDINE REDUCTASE (HUMAN-BRAIN) BY PLATINUM(II) COMPLEXES [J].
ARMAREGO, WLF ;
OHNISHI, A .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1987, 164 (02) :403-409
[7]  
BLAIR JA, 1982, LANCET, V1, P964
[8]   DIHYDROPTERIDINE REDUCTASE-ACTIVITY - LACK OF ASSOCIATION WITH SERUM ALUMINUM LEVELS AND COGNITIVE-FUNCTIONING IN PATIENTS WITH END-STAGE RENAL-DISEASE [J].
BOLLA, KI ;
MILSTIEN, S ;
BRIEFEL, G ;
WIELER, L ;
KAUFMAN, S .
NEUROLOGY, 1991, 41 (11) :1806-1809
[9]  
Cutler P, 1987, Arch Toxicol Suppl, V11, P227
[10]  
Fox M.R.S., 1988, Handbook on Toxicity of Inotganic Compounds, P345